Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Editorial Volume 7 Issue 1

Inveterate and Girdling-Congenital Peribronchial Myofibroblastic Tumour

Anubha Bajaj*

Department of Histopathology, Panjab University/A, B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Department of Histopathology, Panjab University/A, B. Diagnostics, India.

Received: November 14, 2023; Published: December 01, 2023

Abstract

Congenital peribronchial myofibroblastic tumour emerges as an extremely exceptional pulmonary tumefaction incriminating neonates and infants. Initially documented as a ‘hamartoma’ in 1949 by Jones, tumefaction was designated as congenital peribronchial myofibroblastic tumour preliminarily in 1993 by Mcginnis., et al. Neoplasm encompasses airways and exhibits peribronchial expansion. The predominantly solid tumefaction is composed of cartilage and interlacing fascicles of spindle shaped cells and elliptical cells.

References

  1. Jones CJ. “Unusual hamartoma of the lung in a newborn infant”. Archives of Pathology (Chic) 2 (1949): 150-154.
  2. McGinnis M., et al. “Congenital peribronchial myofibroblastic tumor (so-called “congenital leiomyosarcoma”). A distinct neonatal lung lesion associated with nonimmune hydrops fetalis”. Modern Pathology 4 (1993): 487-492.
  3. Zhou P., et al. “Congenital peribronchial myofibroblastic tumor (CPMT): a case report with long term follow-up and next-generation sequencing (NGS)”. BMC Paediatric1 (2023): 184.
  4. Kim Y., et al. “Congenital peribronchial myofibroblastic tumor: a case study and literature review”. Korean Journal of Pathology 2 (2013): 172-176.
  5. Grodzka A., et al. “Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy”. EXCLI Journal 22 (2023): 415-432.
  6. Xia Bo., et al. “A Congenital Peribronchial Myofibroblastic Tumor Detected in a Premature Infant at 28 Weeks but That Resolved in the Late Stage of Pregnancy: A Case Report”. Medicine42 (2015): e1842.
  7. Brock KE., et al. “Congenital peribronchial myofibroblastic tumor: case report of an asymptomatic infant with a rapidly enlarging pulmonary mass and review of the literature”. Annals of Clinical and Laboratory Science 1 (2015): 83-89.
  8. Image 1 Courtesy: Diagnostic pathology, biomed central
  9. Image 2 Courtesy: Medical library.com

Citation

Citation: Anubha Bajaj. “Inveterate and Girdling-Congenital Peribronchial Myofibroblastic Tumour".Acta Scientific Gastrointestinal Disorders 7.1 (2023): 01-03.

Copyright

Copyright: © 2023 Anubha Bajaj. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US